← Leaderboards
Ulrich Bierbach
Wake Forest University
$1,800,552
Attributed
$1,800,552
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $231.4K · FY2005–12$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$1,800,552 · 1
By mechanism
R01$1,800,552 · 1
Top collaborators
No co-investigators on record.
Most similar at Wake Forest University
Same institution · by research overlap
- Alan J Townsend$3,980,665
Others in their field
Top investigators on “Cisplatin”
- Philip J Disaia · University Of California Irvine$57,355,877
- Robert C Park · American College Of Ob And Gyn$16,339,593
- Aziz Sancar · University Of North Carolina Chapel Hill$11,887,517
- Manijeh N Goldberg · Privo Technologies, Llc$11,254,955
- Lois B. Travis · University Of Rochester$11,212,396
- Stephen J Lippard · Boston University Medical Campus$9,887,688
Research focus
CisplatinCytotoxicityPlatinumAdductDna DamageAcridinesAntineoplastic AgentsBinding (Molecular Function)AnalogChemistryChemical StructureBiologicalCancer CellCancer Cell LineAffectChemotherapyCell KillingCell-Free SystemCellsBaseBasic ScienceChemical PropertyAdverse EffectsCell Death
Grant awards (8)
Novel DNA-metalating Hybrid Anticancer Agents$220,019
R01 · FY2012 · CA · contact PI
Novel DNA-metalating Hybrid Anticancer Agents$223,135
R01 · FY2011 · CA · contact PI
Novel DNA-metalating Hybrid Anticancer Agents$231,408
R01 · FY2010 · CA · contact PI
Novel DNA-metalating Hybrid Anticancer Agents$229,541
R01 · FY2009 · CA · contact PI
Novel DNA-metalating Hybrid Anticancer Agents$222,078
R01 · FY2006 · CA · contact PI
Novel DNA-metalating Hybrid Anticancer Agents$226,016
R01 · FY2005 · CA
Novel DNA-metalating Hybrid Anticancer Agents$224,639
R01 · FY2004 · CA
Novel DNA-metalating Hybrid Anticancer Agents$223,716
R01 · FY2003 · CA